Target intelligence / Profile preview

Oesophagostomum dentatum levamisole-sensitive nicotinic acetylcholine receptor (Ode-L-nAChR)

Target
Ode-L-nAChR
Molecular classification
Ion channel, Nicotinic acetylcholine receptor, Cys-loop ligand-gated ion channel, Receptor
01

Overview

The Oesophagostomum dentatum levamisole-sensitive nicotinic acetylcholine receptor (Ode-L-nAChR) is a pentameric ligand-gated ion channel located at the neuromuscular junction of the parasitic nematode O. dentatum, commonly known as the nodular worm of pigs (Source: 1.1.2, 1.3.2). This receptor is a member of the Cys-loop superfamily and is typically composed of subunits such as UNC-38, UNC-63, UNC-29, and ACR-8 (Source: 1.1.2, 1.3.4). Its primary biological function is to mediate fast excitatory neurotransmission, which triggers muscle contraction and enables locomotion (Source: 1.1.1, 1.3.2). In veterinary medicine, the Ode-L-nAChR is a critical therapeutic target for anthelmintic drugs like levamisole and pyrantel (Source: 1.1.2, 1.3.2). These drugs act as potent agonists, causing prolonged activation of the receptor, which leads to spastic paralysis and the subsequent expulsion of the worm from the host's intestinal tract (Source: 1.3.2, 1.4.4). The receptor exhibits pharmacological diversity, with different conductance subtypes (e.g., G35) identified through electrophysiological studies (Source: 1.2.1, 1.3.2). However, the widespread use of these anthelmintics has led to the emergence of drug resistance, often characterized by changes in receptor subunit expression or composition (Source: 1.3.1, 1.4.4). Understanding the molecular structure and diversity of these receptors is essential for developing next-generation anthelmintics to overcome resistance in livestock parasites (Source: 1.1.1, 1.4.3).

Other names
L-type nicotinic acetylcholine receptorLevamisole receptorOde-L-AChROesophagostomum dentatum L-nAChR
02

Mechanism of action

Agonist; induces spastic paralysis by causing persistent depolarization of nematode muscle cells, leading to the expulsion of the parasite from the host.

03

Biological functions

Neuromuscular transmissionMuscle contractionLocomotionSignal transduction
04

Disease associations

InfectionHelminthiasis
05

Safety considerations

Anthelmintic resistanceCross-resistance between cholinergic agonistsHost toxicity at high dosesPolygenic resistance mechanisms
06

Interacting drugs

Levamisole

7 more in the full profile.

07

Biomarkers

unc-63 expression levelsunc-29 expression levelsacr-8 expression levelsacr-21 transcript abundanceacr-25 transcript abundance

Beyond the preview

Go deeper on Oesophagostomum dentatum levamisole-sensitive nicotinic acetylcholine receptor (Ode-L-nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oesophagostomum dentatum levamisole-sensitive nicotinic acetylcholine receptor (Ode-L-nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call